Sulbactam-mediated inhibition of TEM-1 β-lactamase increases specific yields of ampicillin-resistant plasmids
Abstract
Ampicillin resistance is the most widely used selection marker in molecular biology. Most ampicillin-resistant plasmids originate from highly active TEM-1 {beta}-lactamase cassette which causes very fast antibiotic decay and negatively affects long-term plasmid retention. The present work proposes a method of controlling the {beta}-lactamase activity by the addition of an irreversible {beta}-lactamase inhibitor. The positive effect of a {beta}-lactamase inhibitor, specifically sulbactam, on plasmid retention is confirmed by much higher specific plasmid yields: 4-8 times higher titres in shake-flask and almost 3 times higher in bioreactor scales were observed. Among all commercially available {beta}-lactamase inhibitors sulbactam provides the best combination of affordability and activity. The sulbactam addition is simple, fast and economic solution allowing to screen thousands of legacy pBR322 or pUC-derived plasmids harbouring TEM-1 {beta}-lactamase cassette without engineering their sequence.
02 /Specification & Classification
Click any tag to browse matching papersReproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Induction of AmpC-mediated-βlactam resistance requires a single lytic transglycosylase in Agrobacterium tumefaciens
W. Figueroa-Cuilan, M. Howell, … P. J. B. Brown·bioRxiv·Sep 10, 2020
- Plasmid-free cheater cells commonly evolve during laboratory growth
A. M. Bedore, C. M. Waters·bioRxiv·May 19, 2023
- Molecular Glue-like Degraders of TEM β-Lactamases by Periplasmic Protease DegP
Emilia K. Taylor, Patrícia Santos Barbosa, … Thomas Lanyon‐Hogg·Angewandte ChemiePeer-reviewed·Oct 30, 2026
- An engineered prodrug selectively suppresses β-lactam resistant bacteria in a mixed microbial setting
Addison M. Duda, Helena R. Ma, … Katherine J. Franz·ACS Infectious DiseasesPeer-reviewed·Jun 12, 2025
- Single-Domain Antibodies as Potent Inhibitors of Clinically Relevant β-Lactamases in Multidrug-Resistant Bacteria
Paloma Osset-Trénor, Markus Proft, Amparo Pascual‐Ahuir·Frontiers in MicrobiologyPeer-reviewed·Jun 10, 2026
- Disruption of undecaprenyl phosphate recycling suppresses ampC beta-lactamase induction in Pseudomonas aeruginosa
Karina Klycheva, Joël Gyger, … Coralie Fumeaux·PLoS PathogensPeer-reviewed·Oct 21, 2025